NYAS: Targeting Tumor Heterogeneity

Call for Abstracts
Deadline: March 8, 2019

Tumor heterogeneity is one of the biggest roadblocks to the success of cancer treatment today. The expansion of research in this area revealed that therapeutic efficacy can vary within various subregions of a single tumor, perhaps on a cell-to-cell basis, and between multiple tumors in one patient. As such, the overwhelming genetic, epigenetic, and cellular diversity of cancer is a critical challenge that needs to be addressed. The field of tumor heterogeneity continues to progress as novel computational models are shared, innovative biopsy techniques are developed, and new data from patient-based longitudinal studies becomes available. This conference will foster a centralized conversation for sharing these advancements, facilitating new collaborations, and building the foundations of knowledge required to tackle this complex and difficult problem.

Register here.